HSP90AA1 and alkaline phosphatase measurement: These findings collectively demonstrate a potential role of HSP90α in the pathogenesis of AP, possibly through its interaction with the NLRP3 inflammasome, suggesting its potential as a novel therapeutic agent for AP treatment.